|
Bo Ahrén, Chairman of the Board Dean of the Faculty of Medicine, Lund University E-mail: bo.ahren@med.lu.se |
|
Mikael Ørum, Vice Chairman of the Board Managing Director, Ventac Partners A/S E-mail: moerum@ventac-partners.com |
|
Anders Åkerlund, Appointed Observer Global Vice President, AstraZeneca E-mail: anders.akerlund@astrazeneca.com |
|
Cristina Glad Executive Vice President, BioInvent International AB E-mail: cg@bioinvent.com |
|
Daniel Spasic Chief Executive Officer, Trial Form Support |
|
|
Eva Engquist Pro Vice-Chancellor, University of Malmö E-mail: eva.engquist@mah.se |
|
|
Jannik Hilsted Chief Medical Officer, Rigshospitalet - Copenhagen University Hospital E-mail: jannik.hilsted@rh.regionh.dk |
|
Jens Christian Sørensen Group Managing Director, The Capital Region of Denmark E-mail: jcs@regionh.dk |
|
Jens Kristian Gøtrik Director General, Medicoindustrien E-mail: jkg@medicoindustrien.dk |
|
Klaus Peter Bøgesø, Appointed Observer Vice President of External Affairs, H. Lundbeck A/S E-mail: kb@lundbeck.com |
|
Lars Onsberg Henriksen Quality Director, Region Sealand E-mail: loh@regionsjaelland.dk |
|
|
Marianne Kock Executive Vice President, Ferring Pharmaceuticals E-mail: marianne.kock@ferring.com |
|
Peter Buhl Jensen Chief Executive Officer, TopoTarget E-mail: pbj@topotarget.com |
|
Peter Kurtzhals Senior Vice President, Novo Nordisk A/S E-mail: pkur@novonordisk.com |
|
Sven Frøkjær Dean, Faculty of Pharmaceutical Sciences, University of Copenhagen E-mail: sf@farma.ku.dk. |
|
Søren Brunak Professor, Center Director, Centre for Biological Sequence Analysis, Technical University of Denmark E-mail: brunak@cbs.dtu.dk |
|
Sören Olofsson Executive Director, Region Skåne E-mail: soren.olofsson@skane.se |
|
Ulla Margrethe Wewer Dean, Faculty of Health Science, University of Copenhagen E-mail: dekan@sund.ku.dk |